Efficacy and Safety of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis

Lee, Hyojeong and Jeong, Gwang Hun and Li, Han and Kim, Min Seo and Kim, Jae Seok and Park, Se Jin and Han, Young Joo and Lee, Keum Hwa and Kronbichler, Andreas and Hong, Sung Hwi and Ghayda, Ramy A. and Luchini, Claudio and Nottegar, Alessia and Koyanagi, Ai and Smith, Lee and Jacob, Louis and Dragioti, Elena and Radua, Joaquim and Cargnin, Sarah and Terrazzino, Salvatore and Thompson, Trevor and Yon, Dong Keon and Lee, Seung Won and Yang, Jee Myung and Wasuwanich, Paul and Shin, Jae Il and Gamerith, Gabriele (2021) Efficacy and Safety of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Systematic Review and Meta-Analysis. European Review for Medical and Pharmacological Sciences. ISSN 2284-0729 (Accepted)

[img] Text
Accepted Version
Restricted to Repository staff only
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (586kB) | Request a copy
Item Type: Journal Article
Keywords: Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor, Tyrosine Kinase, Meta-Analysis
Faculty: Faculty of Science & Engineering
SWORD Depositor: Symplectic User
Depositing User: Symplectic User
Date Deposited: 06 Apr 2021 14:43
Last Modified: 09 Sep 2021 18:51
URI: https://arro.anglia.ac.uk/id/eprint/706477

Actions (login required)

Edit Item Edit Item